Glaukos (GKOS) Shares Outstanding (2014 - 2026)
Glaukos' (GKOS) quarterly Shares Outstanding (Entity) came in at $58.9 million in Q2 2026, up 2.81% year-over-year from $57.2 million in Q2 2025, and up 0.86% quarter-over-quarter from $58.4 million in Q1 2026.
Analysis
Glaukos (GKOS) Shares Outstanding (2014 - 2026) Analysis & Trends
Glaukos (GKOS) has reported Shares Outstanding (Entity) for 13 consecutive years, with $58.9 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Shares Outstanding (Entity) rose 2.81% year-over-year to $58.9 million in Q2 2026; TTM through Jun 2026 was $58.9 million, a 2.81% increase from a year earlier, with the FY2025 full-year figure at $57.5 million, up 1.89% from the prior year.
- Shares Outstanding (Entity) was $58.9 million for Q2 2026 at Glaukos, up from $58.4 million in the prior quarter.
- Over five years, Shares Outstanding (Entity) peaked at $58.9 million in Q2 2026 and troughed at $47.1 million in Q1 2022.
- A 5-year average of $52.6 million and a median of $52.3 million in 2024 frame the typical range for Shares Outstanding (Entity).
- Across the five-year window, Shares Outstanding (Entity) gained 1.68% in 2022 and gained 14.91% in 2024, its largest moves.
- Over 5 years, Shares Outstanding (Entity) stood at $47.8 million in 2022, then rose by 2.86% to $49.1 million in 2023, then climbed by 14.91% to $56.4 million in 2024, then grew by 1.89% to $57.5 million in 2025, then advanced by 2.34% to $58.9 million in 2026.
- The last three Shares Outstanding (Entity) figures came in at $58.9 million (Q2 2026), $58.4 million (Q1 2026), and $57.5 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.57 Bn | 178.97 Bn | 7.27 Bn | 1.74 Bn |
| 2 | Intuitive Surgical | 124.13 Bn | 118.91 Bn | 1.96 Bn | 354.10 Mn |
| 3 | Medtronic | 118.29 Bn | 109.47 Bn | 6.34 Bn | 1.28 Bn |
| 4 | Stryker | 104.60 Bn | 101.12 Bn | 4.50 Bn | 383.50 Mn |
| 5 | Boston Scientific | 66.50 Bn | 65.97 Bn | 3.85 Bn | 1.47 Bn |
| 6 | Edwards Lifesciences | 49.72 Bn | 45.46 Bn | 1.35 Bn | 576.40 Mn |
| 7 | Alcon | 33.97 Bn | 32.51 Bn | 1.68 Bn | 493.20 Mn |
| 8 | Dexcom | 32.23 Bn | 30.29 Bn | 830.00 Mn | 382.20 Mn |
| 9 | Steris | 21.16 Bn | 20.68 Bn | 684.20 Mn | 97.60 Mn |
| 10 | Glaukos | 10.68 Bn | 10.57 Bn | 151.59 Mn | 58.82 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 58.82 Mn |
| Mar 31, 2026 | 58.02 Mn |
| Dec 31, 2025 | 57.19 Mn |
| Sep 30, 2025 | 57.40 Mn |
| Jun 30, 2025 | 57.21 Mn |
| Mar 31, 2025 | 56.64 Mn |
| Dec 31, 2024 | 52.76 Mn |
| Sep 30, 2024 | 55.04 Mn |
| Jun 30, 2024 | 50.72 Mn |
| Mar 31, 2024 | 49.58 Mn |
| Dec 31, 2023 | 48.43 Mn |
| Sep 30, 2023 | 48.68 Mn |
| Jun 30, 2023 | 48.28 Mn |
| Mar 31, 2023 | 47.88 Mn |
| Dec 31, 2022 | 47.44 Mn |
| Sep 30, 2022 | 47.61 Mn |
| Jun 30, 2022 | 47.36 Mn |
| Mar 31, 2022 | 47.05 Mn |
| Dec 31, 2021 | 46.42 Mn |
| Sep 30, 2021 | 46.74 Mn |